619 filings
Page 10 of 31
4
William Roland Mann
28 Jul 20
NeuBase Therapeutics / William Roland Mann ownership change
4:22pm
3
William Roland Mann
28 Jul 20
NeuBase Therapeutics / William Roland Mann ownership change
4:17pm
8-K
NBSE
NeuBase Therapeutics Inc
28 Jul 20
NeuBase Therapeutics Strengthens Senior Management Team with Appointment of Industry Veteran William Mann, Ph.D., MBA as Chief Operating Officer
8:16am
DEFA14A
NBSE
NeuBase Therapeutics Inc
1 Jul 20
Additional proxy soliciting materials
5:12pm
DEF 14A
NBSE
NeuBase Therapeutics Inc
Definitive proxy
1 Jul 20
5:00pm
4
Lipizzaner LLC
10 Jun 20
NeuBase Therapeutics / Dietrich A Stephan ownership change
11:50am
8-K
NBSE
NeuBase Therapeutics Inc
9 Jun 20
Other Events
4:30pm
4
Lipizzaner LLC
26 May 20
NeuBase Therapeutics / Dietrich A Stephan ownership change
4:39pm
10-Q
2020 Q2
NBSE
NeuBase Therapeutics Inc
Quarterly report
14 May 20
5:16pm
8-K
NBSE
NeuBase Therapeutics Inc
14 May 20
NeuBase Therapeutics Reports Financial Results for the Second Fiscal Quarter of 2020
4:06pm
4
Lipizzaner LLC
4 May 20
NeuBase Therapeutics / Dietrich A Stephan ownership change
3:25pm
4
NBSE
NeuBase Therapeutics Inc
4 May 20
NeuBase Therapeutics / DOV A MD GOLDSTEIN ownership change
2:18pm
4
Backenroth Samuel
4 May 20
NeuBase Therapeutics / Samuel Backenroth ownership change
12:28pm
4
Eric I Richman
4 May 20
NeuBase Therapeutics / ERIC I RICHMAN ownership change
9:56am
SC 13G/A
NBSE
NeuBase Therapeutics Inc
1 May 20
NeuBase Therapeutics / HIRSCHMAN ORIN ownership change
4:17pm
8-K
NBSE
NeuBase Therapeutics Inc
30 Apr 20
NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
4:11pm
424B5
NBSE
NeuBase Therapeutics Inc
29 Apr 20
Prospectus supplement for primary offering
4:21pm
8-K
NBSE
NeuBase Therapeutics Inc
29 Apr 20
NeuBase Therapeutics Announces Pricing of $31,500,000 Public Offering of Common Stock
12:00am
424B5
NBSE
NeuBase Therapeutics Inc
27 Apr 20
Prospectus supplement for primary offering
4:23pm
8-K/A
NBSE
NeuBase Therapeutics Inc
3 Apr 20
Financial Statements and Exhibits
5:10pm